Produzione Scientifica
Found 11 results
Filters: Keyword is prognosis [Clear All Filters]
NOD2 Is Regulated by MIR-320 in Physiological Conditions but this Control Is Altered in Inflamed Tissues of Patients with Inflammatory Bowel Disease,
, Inflammatory Bowel Diseases, Volume 22, Number 2, p.315-326, (2016)
The IASLC/ITMIG thymic epithelial tumors staging project: Proposals for the N and M components for the forthcoming (8th) edition of the TNM classification of malignant tumors,
, Journal of Thoracic Oncology, Volume 9, Number 9, p.S81-S87, (2014)
Role of HMGB1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel disease,
, Inflammatory Bowel Diseases, Volume 20, Number 8, p.1448-1457, (2014)
Concomitant CXCR4 and CXCR7 expression predicts poor prognosis in renal cancer.,
, Curr Cancer Drug Targets, 2010 Nov, Volume 10, Issue 7, p.772-81, (2010)
Differential role of CD133 and CXCR4 in renal cell carcinoma.,
, Cell Cycle, 2010 Nov 15, Volume 9, Issue 22, p.4492-4500, (2010)
A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: An observational prospective study,
, Breast Cancer Research, Volume 10, Number 5, (2008)
Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancer,
, European Journal of Surgical Oncology, Volume 34, Number 5, p.593-598, (2008)
Prognostic value of HER2 and progesterone receptor expression in endometrial carcinoma with positive peritoneal washing,
, Anticancer Research, Volume 27, Number 4 C, p.2839-2844, (2007)
The cytoskeleton regulatory protein hMena (ENAH) is overexpressed in human benign breast lesions with high risk of transformation and human epidermal growth factor receptor-2-positive/hormonal receptor-negative tumors,
, Clinical Cancer Research, Volume 12, Number 5, p.1470-1478, (2006)
Ten years of experience with weekly chemotherapy in metastatic breast cancer patients: Multivariate analysis of prognostic factors,
, Anti-Cancer Drugs, Volume 17, Number 10, p.1193-1200, (2006)
Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification,
, Cancer Research, Volume 59, Number 14, p.3365-3368, (1999)